Media coverage about Sientra (NASDAQ:SIEN) has trended somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sientra earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news articles about the medical instruments supplier an impact score of 47.6541015676576 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

SIEN has been the topic of a number of research analyst reports. William Blair upgraded Sientra from a “market perform” rating to an “outperform” rating in a research report on Wednesday, September 13th. Lake Street Capital reiterated a “buy” rating and set a $15.00 target price (up previously from $11.00) on shares of Sientra in a research report on Wednesday, August 2nd. Canaccord Genuity initiated coverage on Sientra in a research report on Monday, August 28th. They set a “buy” rating and a $14.00 target price on the stock. Stifel Nicolaus reiterated a “hold” rating and set a $14.00 target price (up previously from $11.00) on shares of Sientra in a research report on Wednesday, September 27th. Finally, Zacks Investment Research cut Sientra from a “hold” rating to a “sell” rating in a research report on Tuesday, August 15th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $13.75.

Shares of Sientra (NASDAQ SIEN) traded down $0.02 during mid-day trading on Friday, reaching $14.01. The company had a trading volume of 86,113 shares, compared to its average volume of 145,101. Sientra has a 1 year low of $7.20 and a 1 year high of $16.68. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.92 and a current ratio of 2.87.

Sientra (NASDAQ:SIEN) last issued its quarterly earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.74) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.68) by ($0.06). The company had revenue of $9.80 million during the quarter, compared to analyst estimates of $10.54 million. Sientra had a negative net margin of 169.77% and a negative return on equity of 68.82%. The business’s revenue was up 50.8% on a year-over-year basis. During the same quarter last year, the firm earned ($0.55) EPS. equities research analysts forecast that Sientra will post -3.14 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at

About Sientra

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Insider Buying and Selling by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.